Elite Pharma Inc
(ELTP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,001 | 5,332 | 1,094 | -683 | -9,182 |
| Depreciation Amortization | 505 | 345 | 176 | 667 | 493 |
| Accounts receivable | 986 | 385 | 310 | 33 | 817 |
| Other Working Capital | -3,333 | -2,271 | -175 | 1,874 | 3,689 |
| Other Operating Activity | -8,967 | -6,873 | -2,169 | -4,656 | 812 |
| Operating Cash Flow | $-3,808 | $-3,081 | $-764 | $-2,765 | $-3,372 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -805 | -513 | -284 | -1,919 | -1,352 |
| Purchase Sale Intangibles | -7 | -6 | 0 | N/A | N/A |
| Other Investing Activity | -7 | -6 | 0 | -30 | -26 |
| Investing Cash Flow | $-812 | $-519 | $-285 | $-1,949 | $-1,378 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -718 | N/A | N/A | N/A | 135 |
| Debt Repayment | N/A | -718 | -718 | -210 | -210 |
| Common Stock Issued | 7,627 | 5,810 | 3,179 | 9,241 | 5,745 |
| Other Financing Activity | -517 | -423 | -109 | -269 | -281 |
| Financing Cash Flow | $6,391 | $4,668 | $2,351 | $8,762 | $5,389 |
| Beginning Cash Position | 11,512 | 11,512 | 11,512 | 7,464 | 7,464 |
| End Cash Position | 13,283 | 12,580 | 12,815 | 11,512 | 8,103 |
| Net Cash Flow | $1,771 | $1,068 | $1,303 | $4,048 | $639 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,808 | -3,081 | -764 | -2,765 | -3,372 |
| Capital Expenditure | -805 | -513 | -284 | -1,919 | -1,352 |
| Free Cash Flow | -4,613 | -3,595 | -1,049 | -4,684 | -4,724 |